List of Excipients in API diphenhydramine hydrochloride, naproxen sodium
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing diphenhydramine hydrochloride, naproxen sodium
Detailed excipient profiles for diphenhydramine hydrochloride, naproxen sodium
Excipient focus: CELLULOSE, MICROCRYSTALLINE
diphenhydramine hydrochloride, naproxen sodium drug variants containing CELLULOSE, MICROCRYSTALLINE
diphenhydramine hydrochloride, naproxen sodium drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
diphenhydramine hydrochloride, naproxen sodium drug variants containing CROSCARMELLOSE SODIUM
diphenhydramine hydrochloride, naproxen sodium drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
diphenhydramine hydrochloride, naproxen sodium drug variants containing FD&C BLUE NO. 1
diphenhydramine hydrochloride, naproxen sodium drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
diphenhydramine hydrochloride, naproxen sodium drug variants containing FD&C BLUE NO. 2
diphenhydramine hydrochloride, naproxen sodium drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
diphenhydramine hydrochloride, naproxen sodium drug variants containing MAGNESIUM STEARATE
diphenhydramine hydrochloride, naproxen sodium drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
diphenhydramine hydrochloride, naproxen sodium drug variants containing POLYETHYLENE GLYCOL
diphenhydramine hydrochloride, naproxen sodium drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ACETATE
diphenhydramine hydrochloride, naproxen sodium drug variants containing POLYVINYL ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Kroger Company | diphenhydramine hydrochloride, naproxen sodium | 30142-753 |
| >Company | >Ingredient | >NDC |
diphenhydramine hydrochloride, naproxen sodium drug variants not containing POLYVINYL ACETATE
Excipient focus: POLYVINYL ALCOHOL
diphenhydramine hydrochloride, naproxen sodium drug variants containing POLYVINYL ALCOHOL
diphenhydramine hydrochloride, naproxen sodium drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Kroger Company | diphenhydramine hydrochloride, naproxen sodium | 30142-753 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
diphenhydramine hydrochloride, naproxen sodium drug variants containing POVIDONE
diphenhydramine hydrochloride, naproxen sodium drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
diphenhydramine hydrochloride, naproxen sodium drug variants containing SILICON DIOXIDE
diphenhydramine hydrochloride, naproxen sodium drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
diphenhydramine hydrochloride, naproxen sodium drug variants containing TALC
diphenhydramine hydrochloride, naproxen sodium drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
diphenhydramine hydrochloride, naproxen sodium drug variants containing TITANIUM DIOXIDE
diphenhydramine hydrochloride, naproxen sodium drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
